SCHEMBL7009405

SCHEMBL7009405

CC=C=C=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL491719 0.71
SCHEMBL252133 0.67
SCHEMBL3257380 0.64
Hydrochloric Acid SCHEMBL8080870 0.64
SCHEMBL3839019 0.61
SCHEMBL11600308 0.58
SCHEMBL1086434 0.58
SCHEMBL1893768 0.58
SCHEMBL3076884 0.58
SCHEMBL8383347 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1272198-A1 USE OF ORGANOPHOSPHOROUS COMPOUNDS FOR PRODUCING A MEDICAMENT FOR TREATING INFECTIONS Jomaa Pharmaka GmbH (DE) 2003-01-08 EP disclosed
WO-2002078714-A1 FORMULATIONS WHICH ARE RESISTANT TO GASTRIC JUICE AND ARE USED TO APPLY ANTI-INFECTIVE COMPOUNDS INHIBITING THE 2-C-METHYLERYTHROSE-4 METABOLIC PATHWAY, AND THE SALTS AND ESTERS OF THE SAME JOMAA PHARMAKA GMBH (DE) 2002-10-10 WO disclosed
WO-2001070237-A1 USE OF ORGANOPHOSPHOROUS COMPOUNDS FOR PRODUCING A MEDICAMENT FOR TREATING INFECTIONS JOMAA PHARMAKA GMBH (DE) 2001-09-27 WO disclosed